PTU - Polskie Towarzystwo Urologiczne
home page
current numbers
archival numbers
list of articles:
list przewodni/covering letter
editor
Scientific Committee
publisher
subscription
advertising
important links

Urinary tract calcium stones and their connection with metaboi.ic disturbances. Part II
Article published in Urologia Polska 1979/32/1.

authors

Jerzy Zieliński, Jerzy Pietrek
Klinika Urologii Instytutu Chirurgii Śl. AM w Katowicach
Kierownik Kliniki: prof. dr J. Zieliński
Dyrektor Instytutu: prof. dr Cz. Sadliński
Klinika Nefrologii Instytutu Chorób Wewnętrznych Śl. AM w Katowicach
Kierownik Kliniki: prof. dr F. Kokot
Dyrektor Instytutu: prof. dr K. Gibiński

summary

The clinical causes of development of calcium stones in the urinary tract include Hypercalciuria due, among other causes, to Hyperparathyroidism, excessive excretion of oxalates with urine, conditions associated with continuous excretion of alkaline urine. and diseases or anomalies of the urinary tract causing urine retention or reflux from the bladder and urinary tract infections connected with these urodynamic disturbances.

references

  1. Alonso J., Somacarrera E,: Scąnning microscopy in renal lithiasis. In: Urinary Calculi. Editors: L. Cifuentes Delatte, A. Rapado, A. Hodgkinson, S. Karger, Basel, 1973, str. 256.— la. Andersen J. A.: Benufestat an urea.se inhibitor for the therapy of infected ureolysis. Inveśt. Urol. 1975, 1,2, 381.
  2. Blacklook N. J., MacLeod M. A.: The effect of cellulose. phosphate on intestinal atosorption and urinary excretion of calcium. Brit. J. Urol. 1974, 46, 385—392.
  3. Blacklock N. J., MacLeod M. A.: Calcium-47 absorption in urolithiasis. Brit J. Urol. 1974, 46, 377—384.
  4. Boyce W. H.: Intranephronic calculosis In surgical biopsie of human kidney. Urinary Calculi 1973, str. 339.
  5. Boyce W. H,: Ultrastructure of human renal calculi. Urinary Calculi 1973, str. 247.
  6. Berg C. J. van den, Hill L. F., Stanbury S. W.: Inositol phosphates and phytic acid as inhibitors of biological calcification in the rat. Clin. Sci. 1972, 43, 377—383.
  7. Brickman A. S., Coburn J. W., Ńorman A. W., Massry S. _G.: Short term effects of l,25-dihydroxychole-calciferol on disordered calcium metabolism of renal failure. Amer. J. Med. 1974, 57, 28—33.
  8. Coe F. L., Canterbury J. M., Firpo J. J,, Reiss E.: Evidęnce for secondary hypenparathyroidisim in idiopathic hypercalciuria. J. Clin. Invest. 1073, 52, 134—142.
  9. Coe F. L., Cavalach A. J.: Hypercalciuria and hyiperuricosuria in patients with calcium nephrolithiasis. New Eng. J. Med. 1974, 291, 1344—?
  10. Coe F. L., Ldwton R. L., Goldstein R. B., Tembe V.: Sodium urate accelerates precipitation of calcium oxalate in vitro. Proc. Soc. Exp. Biol. Med. 1975, 149, 926.
  11. Cygan Z., Waroński W., Zieliński J.: Związek między składem chemicznym kamieni moczowych a klinicznym oibrazem kamicy. Post. Hig. Med. Dośw. 1959, 13, 72.
  12. Dent C. E., Harper C. M., Parfitt A. M,: The effect of cellulose phosphate on calcium metaibolism in patients with hypercalciuria. Clin. Sci. 1964, 27, 4,17—425.
  13. Dent C. E., Stamp T. C. B.: Treatment of primary hyperoxca-luria. Axch. Dis. Childh. 1970, 45, 735—745.
  14. Dent C. E., Sutor D. J.: Pre-sence or absence of inhibitor of calcium oxalate orystal growth in urine of normals and of stonę-formers.' Lancet 19)71, 2, 775—778.
  15. Dick -M.: A simplified urinary oxalate method. Proc. Ass. Clin. Biochemists 1967, str. 186—l87.
  16. Dowling R. Hi, Rose G-. A., SUtor D. J.: Hypefoxaluria and renal calculi in ileal disease. Lancet 1971, li, 11031—1106.
  17. Duart G. G., Winnacker J. L., Becker K. L., Puce A.: Thiazideinduced hyipercalcemia. New Eng. J. Med. 1971, 284, 828—830.
  18. Dudley F. J., Blackburn C. R. B.: Extraskeletal calcificaticin complicating orał neutral phosiphaite therapy. Lancet 11970, 2, 628—630.:
  19. Fogarty A. J.: The signifcance of sodium in renal stone formation. Brit. J. Urol. 1971, 43, 403—405.
  20. Funok-Brentano J. L: Diagnostiąue de rhyperparathyroidie primaire chez les sujets atteint de lithiase renale ou de neiphrocalcinose. Urol. Intern. 1965, 19, I1O8.
  21. Gershoff S. N., Prien S. L.: Effect of daily MgO and vitamin B6 administration to patients with recurring calciuim oxa,late kidney stones. Am. J. Clin. Nutr. 1967, 20, 398.
  22. Gibbs D. A., Watts R. W. L.: Biochemical studies in the treatment of primary hyiperoxaluria. Arch. Dis. Childh. 1967, 42, 505.
  23. Haussler M. R., Bursac K. M., Bone H., Pak C. Y. C: Increased circulating 1,25-dihydroxyvitaimin D3 in patients with primary hyperparathyroidism. Clin. Bes. 1975, 23, 322a.
  24. Harrison A. R., Rose G. A.: The late results of paratyreoidectomy in patients with calculus or neiphrocalcinosis. Urinary Calculi 1973,, str. 354.
  25. Hodgkinson A., Marshall R. W., Cochran M.: Diurnal variations in calcium phosphate and calcium oxalate activity products in normal and- stone, forming urines. Israel J. Med'. Sci. 1971, 7, 1230—1234.
  26. Howard J. E., Thomas W. C. Jr.: Control of crystallization in urine. Amer. J. Med. 1968, 45, 693—099.
  27. Keyhes W. M., Barnes' B. A., Cope O.: Urinary excretion of calcium and magnesium in man using a diet with a very low content of these minerals. Proc. Roy. Soc. Med. 1971, 64, 152—>153.
  28. Kokot F., Pietrek J.: Zur Pathophysiologie und Klinik des Parathormons. Zschr. ges. inn. Med. L975, 30, 777—781.
  29. Kollowitz A. A., Kracht H., Brauner R., Lohe E.: Klinische und Laborbefunde bei 470 "Patienten mit Kalziumsiteinen der oberen Harnwege. Urol. int. 1969, 24, 318—329.
  30. Lemann J. Jr., PieriTig W. E., Lennon E. J.: Possible role of carbohydrate induced calciuria in calcium oxolate kidney stone formation. New Eng. J. Med. 1969, 280, 232—237.
  31. Leisinger H. J., Mayor G., Zingg E.: Atyipische Lokalisation der Parathy-reoidea — Adenome beim primaren Hyperparathyreoidisimum. Urologe A, 1.-973, 12, 177.
  32. Leisinger H. J., Schmucki O., Mayor C: Bedeutung des primaren Hyperparathyreoidisrnus in der Urologie. Therap. Umschau 1&75, 32, 83.
  33. MacGregor J., Robertson W. G., Nordin B. E. C: Octacalcium phospha-phosphate: the phase governing the soluibility equiilibriuim in apatitic calculi. Brit. J. Urol. 1965, 37, 518,
  34. Marshall V., White R. H., Saintonge M. C. de, te: the phase governing the sołuibdlity eąuilibrium in apatitic calculi, Brit. J. Urol. 1975, 47, 1,17.
  35. Middler S., Pak C. Y. C, Murad F., Bartter F. C: Thiazide diuretics and calcium metabolism. Metabolism 1(973, 22, 139—,146.
  36. Ohata M., Pak C. Y. C: The effect of diphosphonate on calcium phoaphate crystallization in urine in vitro. Kidney Int. 1973, 4, 40)1—406.
  37. O'Riordan J. L. H., Watson L., Woodhead J. S.: Secretion of paratyhoid hormoiie in primary hyperparathyroidisim. Clin. Endocr. 1972, li, 149—1155
  38. Pak C. Y. C: Physico-chemical basis for formation of renal stones of calcium phosphate origin: calcu-lation of the degree of saturation of urine with respect to brushite. J. Clin. Invest. 11969, 48, 1914.
  39. Pak C. Y. C, Delea C. S., Bartter F. C: Successful treatment of recurrent nephroMthiaisis (calcium stones) with cellulose phosiphate. New Eng. J. Med. 1974, 29'0, 175—?
  40. Pak C. Y. C, Kaplan R. A., Townsend J., Waters O.: A simple test for the diagnosis of afosorptive, resorpitive and renal hyipercalciurias. New Eng. J. Med. 1975, 292, 497.
  41. Parfitt A. M.: Chlorothiazide — induced hypercalcemia in juvenile oste-pporosis and hyiperparathyroidism. New Eng. J. Med. 1969, 281, 55—59.
  42. Parfitt A. M.( Higgins B. A., Nassim J. R., Collins J. A., Hilb A.: Metabolic stidues in patients with hypercalciuria,. Clin. Sci. 1964, 27, 463—482.
  43. Patrzyk W.: Skład chemiczny kamieni moczowych a zawartość ich składników we krwi i w moczu. Rozprawa doktorska. Śląska Akademia Medyczna 1975.
  44. Peacock M., Hodgkin­son A., Nordin B. E. C: Importanee of dietary calcium in the definition of hypercalciuria. Brit. Med. J. 1967, 3, 469'—471.
  45. Pelc T.: Gospodarka wap-niowo-fosforanowa w kamicy i w zakażeniu dróg moczowych. Pol. Tyg. Lek. 1966, 21, 1919.
  46. Pietrek J.: Wpływ aminofiliny na nerkowe wydalanie wapnia i fosforanów w wytoranyoh &tanach chorobowych. Pol. Arch. Med. Wewn. 1974, 51, 389—400.
  47. Pietrek J., Kokot F.: Treatment of patients with calciumcontaining renal stones with cellulose phosphate. Brit. J. Urol. 1973, 45, 136—143.
  48. Prien E. L., Gershoff S. E.: Magnesium oxide — pyridoxine therapy for recur­rent calcium oxalate calculi. J. Urol. 1974, 112, 509.
  49. Reinhold J. G., Nasr K., Lahingarzadeh A., Hedayati H.: Effects of purified phytate and phyitate-rich bread uipon metaibolisim of zinc, calcium, phosphorus and nitrogen in man. Lancet 1973, 1, 283—288.
  50. Revusova V., Zvara V., Gratzlova J.: Urinary oxalate excretion in patients with urolithiasis. Urol. Int. Wli, 26, 277—382.
  51. Robertson W. G.: Measurement of ionized calcium in biological fluids. Clin. Ohim. Acta 1S69, 24, 149—158.
  52. Robertson W. G., Hambleton J., Hodgkinson A.: Peptide inhibitors of calcium phoisiphate precipitation in the urine of normal and stone forming men. Clin. Chim. Acta 1969, 25, 247—254.
  53. Robertson W. G., Morgan D. B.: The distribution of urinary calcium excretion in normal persons and stone-formers. Clin. Chim. Acta 1972, 37, 503—508.
  54. Robertson W. G., Peacock M.t Nordin B. E. C: Cadcium oxolate crystalluria and urine saturation in recurrent renal stone formers. Clin. Sci. 1971, 40, 365—374.
  55. Sawicki A., Hartwig W.: Nowa prosta metoda kliniczna ułatwiająca rozpoznanie pierwotnej nadczynności przytarczyc. Pamiętnik XV Zjazdu Pol. Tow. Urol. w Wiśle (1976) wyd. w r. 1977.
  56. Shen F., Baylink D., Nielson R., Hughes M., Haussler M. R.: Increased serum li,25-dihydroxycholecalciferol in patients with idiopathic hyper­calciuria. Clin. Res. 1'975, 23, 423a.
  57. Smith L. H., Fromm H., Hoffman A. F.: Acąuired hyiperoxaluria nephrolithiasis and intestinal disease. New Eng. J. Med. 1972, 286, 1371i—il,375.
  58. Sommerkamp H.: Renale tubulare Acidosen als Ursache der Harnsteinbildung. in: Pathogenese und Klinik der Harnsteine 1974, 3, 109.
  59. Takasaki E.: Report on recurrent urolithiasis. Jap. J. Urol. 1974, 65, 423.
  60. Takasaki E.: Urinary magnesium and oxalic acid excretion in patients with recurrent- oxalate urolithiasis. Inyest. Urol. 1975, 12, 251.
  61. Taylor W. H.: Renal cakuli and self-medication with multivitamin preparations containing vitamin D. Clin. Sci. 1972, 42, 515—522.
  62. Tomlinson S., Barling P. M., Albano J. D. M., Brown B. L., 0'Riordan J. L. H,: The effects of exogeneous parathyroid hormone on plasma and urinary adenosine 3', 5' — cyelic monophosphate in man. Clin. Sci. Molec. Med. 1974, 47, 481—492.
  63. Wills M. R.: Norimocalceniic primary hypeiiparathyroidisim. Lancet 1971, 1, 849—852.
  64. Zarembski P. M., Hodgkinson A.: Some factors influencing the urinary excretion of oxalic acid in man. Clin. Ghim. Acta 1869, 25, ?
  65. Zieliński J.: Kamica moczowa w Polsce. Urol. Pol. 1954, 7, I1I18—127.
  66. Zieliński J.: Rzeczywiste i rzekome możliwości farmakologicznego rozpuszczania ka­mieni moczowych i zapobiegania ich nawrotom. Pol. Przeg. Chir. 1975, 47, 221.

correspondence

Klinika Urologiczna
ul. Warszawska 52
40-008 Katowice